China SXT Pharmaceuticals, Inc. (SXTC)
NASDAQ: SXTC · Real-Time Price · USD
2.130
+0.090 (4.41%)
At close: Mar 9, 2026, 4:00 PM EDT
2.140
+0.010 (0.47%)
After-hours: Mar 9, 2026, 7:08 PM EDT

China SXT Pharmaceuticals Ratios and Metrics

Millions USD. Fiscal year is Apr - Mar.
Fiscal Year
CurrentFY 2025 FY 2024 FY 2023 FY 2022 FY 2021 2020 - 2016
Period Ending
Mar '26 Mar '25 Mar '24 Mar '23 Mar '22 Mar '21 2020 - 2016
Market Capitalization
234131128
Upgrade
Market Cap Growth
52.70%3516.29%-67.93%-73.70%-59.22%86.67%
Upgrade
Enterprise Value
-1826-721418
Upgrade
Last Close Price
2.04374.232015.998507.96167996.641103977.92
Upgrade
PS Ratio
1.3019.720.491.504.335.78
Upgrade
PB Ratio
0.082.220.070.200.691.73
Upgrade
P/TBV Ratio
0.102.230.070.200.691.73
Upgrade
P/FCF Ratio
----54.69-
Upgrade
P/OCF Ratio
----41.95-
Upgrade
EV/Sales Ratio
-14.76-0.795.323.73
Upgrade
EV/FCF Ratio
----67.30-
Upgrade
Debt / Equity Ratio
0.060.060.270.610.650.76
Upgrade
Debt / FCF Ratio
----52.20-
Upgrade
Net Debt / Equity Ratio
-0.99-1.12-0.60-0.57-0.29-0.07
Upgrade
Net Debt / EBITDA Ratio
2.416.644.431.680.980.62
Upgrade
Net Debt / FCF Ratio
7.337.354.3355.52-23.240.81
Upgrade
Asset Turnover
0.050.080.070.060.080.17
Upgrade
Inventory Turnover
0.701.421.981.881.101.60
Upgrade
Quick Ratio
4.043.331.511.311.141.00
Upgrade
Current Ratio
4.373.541.601.351.311.25
Upgrade
Return on Equity (ROE)
-50.30%-22.50%-21.65%-38.15%-35.42%-21.67%
Upgrade
Return on Assets (ROA)
-18.27%-7.48%-4.96%-10.42%-9.53%-4.88%
Upgrade
Return on Invested Capital (ROIC)
-6457.21%-143.27%-35.35%-58.67%-39.22%-18.57%
Upgrade
Return on Capital Employed (ROCE)
-41.10%-17.10%-14.70%-34.90%-31.60%-13.80%
Upgrade
Earnings Yield
-444.00%-9.62%-326.32%-200.45%-50.96%-9.96%
Upgrade
FCF Yield
-137.29%-6.84%-203.80%-5.12%1.83%-5.11%
Upgrade
Source: S&P Capital IQ. Standard template. Financial Sources.